Robert Daniels
Venture Partner at Brandon Capital Partners
New South Wales
Overview
Work Experience
Venture Partner
2021 - Current
Joined the Brandon team to get back involved with some exciting early stage biotech opportunities.
Head Elastagen
2020 - 2021
Worked with incoming Abbvie staff following the acquisition of Allergan to ensure the Elastagen business, as part of Allergan Aesthetics, was successfully integrated into Abbvie's Asset Strategy, operations and manufacturing teams.
AbbVie is a pharmaceutical company that discovers, develops, and markets medicines.
Raised $15,000,249,999.00.
Head Elastagen
2018 - 2020
Led the integration of Elastagen's business and pipeline products into Allergan, interacting cross-functionally with regs, clinical, biologics and device groups in US and Europe.
Repros Therapeutics is focused on the development of new drugs to treat hormonal and reproductive system disorders.
Raised $29,499,310.00 from New Enterprise Associates.
Chief Executive
2008 - 2018
Director and CEO, led the business from lab bench start up in 2008 to a global operation with a late stage clinical pipeline. Led the sale & integration of the business into Allergan following Elastagen's acquisition for ~A$350M, and again into Abbvie following its acquisition of Allergan.
Associate
2008 - 2010
VP Asia Pacific
2007 - 2008
Chief Commercial Officer
2004 - 2007
COO
2001 - 2003